DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.
This report (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of API are studied here. The increasing importance of API outsourced manufacturing activities and the impact on the pharmaceutical industry are covered in the report.
The API market is segmented into categories: molecular entity, manufacturer type, end use and region. The API market is segmented into two molecular entity groups: natural and synthetic API. Synthetic APIs are further segmented into chemical synthesis, biocatalytic and cell culture. Under the category of molecular entity, APIs are segmented into small molecules and large molecules. By sourcing type, the market is segmented into captive market, merchant market and contract manufacturing organization (CMO). In terms of end use, the market is segmented into clinical trial use and commercial use.
In terms of geography, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, Latin America and the Middle East. The API market is very fragmented. Therefore, attempts have been made to present the market share held by selected companies.
- Aurobindo Pharma
- BASF AG
- Mylan N.V.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Active Pharmaceutical Ingredients-Introduction
Chapter 4 Active Pharmaceutical Ingredients Market by Manufacturer/ Service Provider
Chapter 5 API Market by End Use
Chapter 6 API by Origin
Chapter 7 API Market by Molecule Type
Chapter 8 API Market by Region
Chapter 9 Supplier Landscape and Key Industry Development
Chapter 10 Company Profiles
Chapter 11 Appendix
For more information about this report visit https://www.researchandmarkets.com/research/958h7x/global_active?w=4